By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Boston, Massachusetts) 

135 Clarendon Street #14R

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


Company News
10 Biotech Stocks Analysts are Upbeat About in May 5/23/2016 8:24:58 AM
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015 3/23/2016 6:40:48 AM
Tesaro (TSRO) Begins Hiring Spree in Anticipation of Its First Drug Approval Next Month 8/12/2015 6:36:29 AM
Tesaro, Inc. (TSRO) Announces Six Abstracts To Be Presented At The 2015 Multinational Association Of Supportive Care In Cancer Annual Meeting 6/25/2015 12:10:00 PM
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014 3:27:58 PM
Boston CEO Conference To Feature Ceos Of Aegerion Pharmaceuticals, Inc. (AEGR), Alkermes plc (ALKS), Alnylam Pharmaceuticals (ALNY), Flex Pharma, Genzyme Corporation (GENZ), Infinity Pharmaceuticals Inc. (INFI), OvaScience (OVAS), Sarepta Therapeutics (SRPT), Tesaro, Inc. (TSRO), Verastem, Inc. (VSTM) And Others June 4th And 5th 5/20/2014 7:03:42 AM
Tesaro, Inc. (TSRO) Announces Election Of Earl M. (Duke) Collier, Jr. To Board Of Directors And Results Of Annual Stockholder Meeting 5/16/2014 9:26:32 AM
Tesaro, Inc. (TSRO) To Present At The UBS 2014 Global Healthcare Conference 5/14/2014 11:48:56 AM
Weak Phase 3 Nausea Drug Data Knocks Back Tesaro, Inc.'s Shares; Stock Down -24.75% At Market Close (Dec. 23, 2013) 12/23/2013 6:52:31 AM
Tesaro, Inc. Announces Presentation of Rolapitant Pharmacokinetic (PK) Data at the MASCC/ISOO International Symposium 6/28/2013 9:00:12 AM